Skin sensitivity can ID responders to galcanezumab for migraine prevention
The presence or absence of nonictal allodynia can be used to identify migraine sufferers who will likely respond to galcanezumab, according to a study published online Feb. 14 in Cephalalgia.
Feb 21, 2023
0
15